Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, 197 Ruijin Er Road, Shanghai, 200025, China.
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary / Schepens Eye Research Institute, Harvard University, Boston, MA, 02114, USA.
BMC Cancer. 2021 Aug 30;21(1):976. doi: 10.1186/s12885-021-08719-2.
Optic nerve astrocytomas (ONAs) are neurological neoplasms in the central nervous system (CNS), and they have the highest incidence rate among all the tumor types in the visual pathway. In this study, we conducted a Surveillance, Epidemiology, and End Results (SEER) -based research to explore the demographic, survival, and prognostic factors of patients diagnosed with ONAs.
Utilizing the SEER database, we retrospectively evaluated data of patients diagnosed with ONAs of all ages from 1984 to 2016. We used the Student's t distribution to test variables of patients and various characteristics, and Kaplan-Meier curve to illustrate overall survival (OS) with 95.0% confidence intervals (CIs). We also performed univariate and multivariate analyses to evaluate various variables' validity on overall survival.
A total of 1004 cases were analyzed, and revealed that age (P<0.001, hazard ratio (HR) = 8.830, 95% CI: 4.088-19.073), tumor grade (P<0.001, HR = 1.927, 95% CI: 1.516-2.450), diagnostic confirmation (P<0.001, HR = 2.444, 95% CI: 1.632-3.660), and histology type (P = 0.046, HR = 1.563, 95% CI: 1.008-2.424) of the tumor were associated with decreased survival.
From this large, comparative study of ONAs, we found that younger age may be considered as a protective indicator, while high-grade astrocytic tumors have a worse prognosis. We also found that diagnostic confirmation and tumor grade were independent prognostic factors in this patient population.
视神经星形细胞瘤(ONAs)是中枢神经系统(CNS)的神经肿瘤,是所有视路肿瘤类型中发病率最高的。本研究通过基于监测、流行病学和最终结果(SEER)数据库的研究,探讨了诊断为 ONAs 的患者的人口统计学、生存和预后因素。
我们回顾性评估了 1984 年至 2016 年所有年龄的 ONAs 患者的 SEER 数据库数据。使用学生 t 分布检验患者和各种特征的变量,使用 Kaplan-Meier 曲线绘制总体生存(OS)曲线,95.0%置信区间(CI)。我们还进行了单变量和多变量分析,以评估各种变量对总生存的有效性。
共分析了 1004 例患者,结果表明年龄(P<0.001,风险比(HR)=8.830,95%CI:4.088-19.073)、肿瘤分级(P<0.001,HR=1.927,95%CI:1.516-2.450)、诊断确认(P<0.001,HR=2.444,95%CI:1.632-3.660)和组织学类型(P=0.046,HR=1.563,95%CI:1.008-2.424)与生存时间缩短相关。
从这项针对 ONAs 的大型、对比研究中,我们发现年轻可能被认为是一种保护指标,而高级别星形细胞瘤的预后较差。我们还发现诊断确认和肿瘤分级是该患者群体中的独立预后因素。